Yissum - Research Development Company of the Hebrew University

Quick-Onset Nasal Delivery of Tramadol for the Treatment of Pain

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

Quick-Onset Nasal Delivery of Tramadol for the Treatment of Pain
Project ID : 7-2008-2191

Description of the technology

New Nasal Technology for Pain Treatment

Categories

Pain treatment

Development Stage

Results in animal modelfor a non-opiate drug, industrial scale up formulation

Results in animal modelfor a new drug combinationin treatment of pain

Highlights

  • Currently, few prescription non-opiate pain drugs achieve acceptable analgesia in more than 50% of treated patients.
  • The new treatments could improve opiate and non-opiate pain therapy

Our Innovation

  • Carrier for enhanced nasal absorption
  • Improved treatment using a formulation based on the IP carrier

Key Features

The drug formulation based on the new carrier:

  • may be administered as nasal drops, spray, aerosol, nebulizer or in a semi-solid preparation such as gel, cream or ointment
  • Contains FDA approved ingredients

Development Milestones

  • Results in animals

The Opportunity

  • Huge market - worldwide, millions of people suffer daily from pain; more than 11 million Americans report pain as a significant disability
  • Opportunity for new and improved formulations for opiate and non-opiate drugs

Project manager

Shani Bullock
VP, Business Development, Healthcare

Project researchers

Elka Touitou
HUJI, School of Medicine - IMRIC
School of Pharmacy- Institute for Drug Research

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Recombinant DNA
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Toxicology Market
  • In vitro Testing, Trials Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Gene Expression, Proteom Research Market
  • Bioinformatics Market
  • Enzymology/Protein Engineering/Fermentation
  • Genetic Engineering Market
  • Clinical Medicine
  • Anatomy, Pathology, Immunology, Physiology
  • Agro and Marine biotech
  • Other Medical/Health Related
  • Therapeutic
  • Diagnostic
  • Life Science & Biotechnology
  • cns

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.